nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—GNRHR—Peptide GPCRs—CXCR1—melanoma	0.0248	0.0314	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—MC1R—melanoma	0.0244	0.031	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—CCR7—melanoma	0.0234	0.0297	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—CXCR1—melanoma	0.021	0.0266	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—GRM1—melanoma	0.0198	0.0252	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—CXCR2—melanoma	0.0194	0.0246	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—CXCR2—melanoma	0.0164	0.0208	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PLCB4—melanoma	0.0161	0.0204	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—EDNRB—melanoma	0.016	0.0202	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB4—melanoma	0.0144	0.0182	CbGpPWpGaD
Gonadorelin—GNRHR—Peptide GPCRs—CXCR4—melanoma	0.0142	0.018	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—F2R—melanoma	0.014	0.0177	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—F2RL1—melanoma	0.0137	0.0173	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2RL1—melanoma	0.0122	0.0155	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—KISS1—melanoma	0.0122	0.0155	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—GRM1—melanoma	0.0111	0.0141	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—melanoma	0.0109	0.0138	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—TAS2R60—melanoma	0.0107	0.0136	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL1—melanoma	0.0106	0.0135	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—melanoma	0.00996	0.0126	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2RL1—melanoma	0.00905	0.0115	CbGpPWpGaD
Gonadorelin—Embolism—Temozolomide—melanoma	0.00905	0.0427	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL1—melanoma	0.00811	0.0103	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KISS1—melanoma	0.00807	0.0102	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—F2R—melanoma	0.00785	0.00996	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR1—melanoma	0.00781	0.00991	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MC1R—melanoma	0.0077	0.00976	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—EDNRB—melanoma	0.0076	0.00965	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR7—melanoma	0.00738	0.00936	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—GNA11—melanoma	0.00718	0.00911	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—melanoma	0.00702	0.00891	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—F2RL1—melanoma	0.00689	0.00874	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—melanoma	0.0068	0.00863	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—GNAQ—melanoma	0.00667	0.00847	CbGpPWpGaD
Gonadorelin—Breast pain—Temozolomide—melanoma	0.00666	0.0314	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—GRM3—melanoma	0.00648	0.00822	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—melanoma	0.00642	0.00815	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—KISS1—melanoma	0.00614	0.00779	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR2—melanoma	0.00611	0.00776	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—TAS2R60—melanoma	0.00604	0.00767	CbGpPWpGaD
Gonadorelin—Embolism—Docetaxel—melanoma	0.00602	0.0284	CcSEcCtD
Gonadorelin—Injection site reaction—Carmustine—melanoma	0.00597	0.0282	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—melanoma	0.00597	0.00757	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCR1—melanoma	0.00595	0.00755	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—MC1R—melanoma	0.00586	0.00744	CbGpPWpGaD
Gonadorelin—Redness—Docetaxel—melanoma	0.00572	0.027	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—GRM1—melanoma	0.00562	0.00713	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCR7—melanoma	0.00562	0.00713	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—TAS2R60—melanoma	0.00549	0.00696	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2R—melanoma	0.0052	0.0066	CbGpPWpGaD
Gonadorelin—Angiopathy—Vemurafenib—melanoma	0.00518	0.0244	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—EDN1—melanoma	0.00517	0.00657	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRB—melanoma	0.00503	0.00639	CbGpPWpGaD
Gonadorelin—Erythema—Vemurafenib—melanoma	0.00497	0.0234	CcSEcCtD
Gonadorelin—Swelling—Carmustine—melanoma	0.00495	0.0233	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CXCR2—melanoma	0.00466	0.00591	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—melanoma	0.00463	0.00587	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PLCB4—melanoma	0.00458	0.00581	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL1—melanoma	0.00458	0.00581	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—WNT5A—melanoma	0.00451	0.00572	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—melanoma	0.00447	0.00567	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCA—melanoma	0.00434	0.0055	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—melanoma	0.00424	0.00538	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL1—melanoma	0.00416	0.00528	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PLCB4—melanoma	0.00416	0.00528	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Vemurafenib—melanoma	0.00405	0.0191	CcSEcCtD
Gonadorelin—Nervous system disorder—Vemurafenib—melanoma	0.00398	0.0188	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—F2R—melanoma	0.00396	0.00502	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—F2RL1—melanoma	0.00389	0.00494	CbGpPWpGaD
Gonadorelin—Injection site reaction—Docetaxel—melanoma	0.00384	0.0181	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—EDNRB—melanoma	0.00383	0.00486	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DRAP1—melanoma	0.00381	0.00484	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MYO7A—melanoma	0.00381	0.00484	CbGpPWpGaD
Gonadorelin—Breast disorder—Temozolomide—melanoma	0.00381	0.018	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—GRM3—melanoma	0.00366	0.00465	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—F2RL1—melanoma	0.00354	0.00449	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Vemurafenib—melanoma	0.0035	0.0165	CcSEcCtD
Gonadorelin—Fatigue—Vemurafenib—melanoma	0.0035	0.0165	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—KISS1—melanoma	0.00347	0.0044	CbGpPWpGaD
Gonadorelin—Constipation—Vemurafenib—melanoma	0.00347	0.0164	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.00343	0.00435	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCR4—melanoma	0.0034	0.00432	CbGpPWpGaD
Gonadorelin—Upper respiratory tract infection—Temozolomide—melanoma	0.00339	0.016	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCR1—melanoma	0.00336	0.00427	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GRM3—melanoma	0.00333	0.00422	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—MC1R—melanoma	0.00331	0.0042	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TAS2R60—melanoma	0.00324	0.00411	CbGpPWpGaD
Gonadorelin—Swelling—Docetaxel—melanoma	0.00318	0.015	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CCR7—melanoma	0.00318	0.00403	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GRM1—melanoma	0.00318	0.00403	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—KISS1—melanoma	0.00315	0.004	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCR1—melanoma	0.00305	0.00387	CbGpPWpGaD
Gonadorelin—Erythema—Bleomycin—melanoma	0.00301	0.0142	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—MC1R—melanoma	0.00301	0.00382	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—melanoma	0.00301	0.00381	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Vemurafenib—melanoma	0.00299	0.0141	CcSEcCtD
Gonadorelin—Asthenia—Vemurafenib—melanoma	0.00291	0.0137	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—RHOB—melanoma	0.00289	0.00367	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GRM1—melanoma	0.00288	0.00366	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCR7—melanoma	0.00288	0.00366	CbGpPWpGaD
Gonadorelin—Pruritus—Vemurafenib—melanoma	0.00287	0.0135	CcSEcCtD
Gonadorelin—Erythema—Dactinomycin—melanoma	0.00281	0.0133	CcSEcCtD
Gonadorelin—Diarrhoea—Vemurafenib—melanoma	0.00277	0.0131	CcSEcCtD
Gonadorelin—Angiopathy—Temozolomide—melanoma	0.00265	0.0125	CcSEcCtD
Gonadorelin—Immune system disorder—Temozolomide—melanoma	0.00263	0.0124	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCR2—melanoma	0.00263	0.00334	CbGpPWpGaD
Gonadorelin—Erythema—Carmustine—melanoma	0.00263	0.0124	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—RHOB—melanoma	0.00262	0.00333	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—EDN1—melanoma	0.00261	0.00331	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—RAC2—melanoma	0.00259	0.00328	CbGpPWpGaD
Gonadorelin—Vomiting—Vemurafenib—melanoma	0.00258	0.0122	CcSEcCtD
Gonadorelin—Headache—Vemurafenib—melanoma	0.00254	0.012	CcSEcCtD
Gonadorelin—Erythema—Temozolomide—melanoma	0.00254	0.012	CcSEcCtD
Gonadorelin—Breast disorder—Docetaxel—melanoma	0.00253	0.012	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CXCL1—melanoma	0.00246	0.00312	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLCB4—melanoma	0.00246	0.00312	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Bleomycin—melanoma	0.00246	0.0116	CcSEcCtD
Gonadorelin—Nausea—Vemurafenib—melanoma	0.00241	0.0114	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CXCR2—melanoma	0.00239	0.00303	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—RAC2—melanoma	0.00235	0.00298	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—WNT5A—melanoma	0.00231	0.00294	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CUL3—melanoma	0.00231	0.00293	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TRRAP—melanoma	0.00231	0.00293	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKR1B10—melanoma	0.00225	0.00285	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—F2R—melanoma	0.00224	0.00284	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—EDNRB—melanoma	0.00217	0.00275	CbGpPWpGaD
Gonadorelin—Pain—Bleomycin—melanoma	0.0021	0.00992	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—F2RL1—melanoma	0.00209	0.00265	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Temozolomide—melanoma	0.00207	0.00978	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—GAB2—melanoma	0.00205	0.0026	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNA11—melanoma	0.00205	0.0026	CbGpPWpGaD
Gonadorelin—Nervous system disorder—Temozolomide—melanoma	0.00203	0.00959	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—F2R—melanoma	0.00203	0.00258	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.00201	0.00255	CbGpPWpGaD
Gonadorelin—Fatigue—Dactinomycin—melanoma	0.00198	0.00932	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—EDNRB—melanoma	0.00197	0.0025	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GRM3—melanoma	0.00196	0.00249	CbGpPWpGaD
Gonadorelin—Pain—Dactinomycin—melanoma	0.00196	0.00925	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCR4—melanoma	0.00192	0.00244	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.00192	0.00244	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNAQ—melanoma	0.0019	0.00241	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Dactinomycin—melanoma	0.00187	0.00884	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—KISS1—melanoma	0.00186	0.00236	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GAB2—melanoma	0.00186	0.00236	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNA11—melanoma	0.00186	0.00236	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.00185	0.00235	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Carmustine—melanoma	0.00185	0.00874	CcSEcCtD
Gonadorelin—Constipation—Carmustine—melanoma	0.00183	0.00865	CcSEcCtD
Gonadorelin—Pain—Carmustine—melanoma	0.00183	0.00865	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.00183	0.00232	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.00183	0.00232	CbGpPWpGaD
Gonadorelin—Abdominal pain—Dactinomycin—melanoma	0.00181	0.00855	CcSEcCtD
Gonadorelin—Hypersensitivity—Bleomycin—melanoma	0.00181	0.00854	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—SKI—melanoma	0.0018	0.00229	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCR1—melanoma	0.0018	0.00229	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Temozolomide—melanoma	0.00179	0.00844	CcSEcCtD
Gonadorelin—Fatigue—Temozolomide—melanoma	0.00179	0.00843	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—MC1R—melanoma	0.00178	0.00225	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PIK3CA—melanoma	0.00177	0.00225	CbGpPWpGaD
Gonadorelin—Pain—Temozolomide—melanoma	0.00177	0.00836	CcSEcCtD
Gonadorelin—Constipation—Temozolomide—melanoma	0.00177	0.00836	CcSEcCtD
Gonadorelin—Asthenia—Bleomycin—melanoma	0.00176	0.00832	CcSEcCtD
Gonadorelin—Angiopathy—Docetaxel—melanoma	0.00176	0.00831	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT3—melanoma	0.00176	0.00223	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Carmustine—melanoma	0.00175	0.00828	CcSEcCtD
Gonadorelin—Immune system disorder—Docetaxel—melanoma	0.00175	0.00827	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CXCR4—melanoma	0.00175	0.00222	CbGpPWpGaD
Gonadorelin—Pruritus—Bleomycin—melanoma	0.00174	0.0082	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—GNAQ—melanoma	0.00173	0.00219	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.00173	0.00219	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GRM1—melanoma	0.0017	0.00216	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCR7—melanoma	0.0017	0.00216	CbGpPWpGaD
Gonadorelin—Abdominal pain—Carmustine—melanoma	0.00169	0.008	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Temozolomide—melanoma	0.00169	0.008	CcSEcCtD
Gonadorelin—Erythema—Docetaxel—melanoma	0.00169	0.00797	CcSEcCtD
Gonadorelin—Hypersensitivity—Dactinomycin—melanoma	0.00169	0.00797	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—SUFU—melanoma	0.00166	0.00211	CbGpPWpGaD
Gonadorelin—Asthenia—Dactinomycin—melanoma	0.00164	0.00776	CcSEcCtD
Gonadorelin—Abdominal pain—Temozolomide—melanoma	0.00164	0.00773	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—AKT3—melanoma	0.00159	0.00202	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.00159	0.00201	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Carmustine—melanoma	0.00158	0.00746	CcSEcCtD
Gonadorelin—Diarrhoea—Dactinomycin—melanoma	0.00157	0.0074	CcSEcCtD
Gonadorelin—Vomiting—Bleomycin—melanoma	0.00156	0.00737	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—RHOB—melanoma	0.00155	0.00197	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BCL2L11—melanoma	0.00155	0.00197	CbGpPWpGaD
Gonadorelin—Asthenia—Carmustine—melanoma	0.00154	0.00726	CcSEcCtD
Gonadorelin—Hypersensitivity—Temozolomide—melanoma	0.00153	0.00721	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—HDAC6—melanoma	0.00149	0.00189	CbGpPWpGaD
Gonadorelin—Asthenia—Temozolomide—melanoma	0.00149	0.00702	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—EDN1—melanoma	0.00147	0.00187	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.00147	0.00186	CbGpPWpGaD
Gonadorelin—Diarrhoea—Carmustine—melanoma	0.00147	0.00692	CcSEcCtD
Gonadorelin—Pruritus—Temozolomide—melanoma	0.00147	0.00692	CcSEcCtD
Gonadorelin—Nausea—Bleomycin—melanoma	0.00146	0.00689	CcSEcCtD
Gonadorelin—Vomiting—Dactinomycin—melanoma	0.00146	0.00688	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CSF2—melanoma	0.00144	0.00183	CbGpPWpGaD
Gonadorelin—Diarrhoea—Temozolomide—melanoma	0.00142	0.00669	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CXCR2—melanoma	0.00141	0.00179	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL8—melanoma	0.00141	0.00179	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.00141	0.00178	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RAC2—melanoma	0.00139	0.00176	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCA—melanoma	0.00138	0.00175	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Docetaxel—melanoma	0.00138	0.0065	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—WNT5A—melanoma	0.00137	0.00173	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VEGFC—melanoma	0.00137	0.00173	CbGpPWpGaD
Gonadorelin—Vomiting—Carmustine—melanoma	0.00136	0.00644	CcSEcCtD
Gonadorelin—Nausea—Dactinomycin—melanoma	0.00136	0.00642	CcSEcCtD
Gonadorelin—Shock—Docetaxel—melanoma	0.00136	0.0064	CcSEcCtD
Gonadorelin—Nervous system disorder—Docetaxel—melanoma	0.00135	0.00638	CcSEcCtD
Gonadorelin—Headache—Carmustine—melanoma	0.00134	0.00634	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—EDN1—melanoma	0.00134	0.0017	CbGpPWpGaD
Gonadorelin—Vomiting—Temozolomide—melanoma	0.00132	0.00622	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CSF2—melanoma	0.00131	0.00166	CbGpPWpGaD
Gonadorelin—Headache—Temozolomide—melanoma	0.0013	0.00613	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—RAC1—melanoma	0.00128	0.00163	CbGpPWpGaD
Gonadorelin—Nausea—Carmustine—melanoma	0.00127	0.00601	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCA—melanoma	0.00126	0.00159	CbGpPWpGaD
Gonadorelin—Nausea—Temozolomide—melanoma	0.00123	0.00581	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—MAP2K2—melanoma	0.00123	0.00156	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—F2R—melanoma	0.0012	0.00152	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Docetaxel—melanoma	0.00119	0.00562	CcSEcCtD
Gonadorelin—Fatigue—Docetaxel—melanoma	0.00119	0.00561	CcSEcCtD
Gonadorelin—Constipation—Docetaxel—melanoma	0.00118	0.00556	CcSEcCtD
Gonadorelin—Pain—Docetaxel—melanoma	0.00118	0.00556	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—RAC1—melanoma	0.00116	0.00148	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDNRB—melanoma	0.00116	0.00147	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTK2B—melanoma	0.00113	0.00143	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Docetaxel—melanoma	0.00113	0.00532	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—GAB2—melanoma	0.0011	0.00139	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNA11—melanoma	0.0011	0.00139	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FLT1—melanoma	0.00109	0.00139	CbGpPWpGaD
Gonadorelin—Abdominal pain—Docetaxel—melanoma	0.00109	0.00514	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CG—melanoma	0.00108	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCR4—melanoma	0.00103	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HDAC2—melanoma	0.00103	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FOXO4—melanoma	0.00103	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNAQ—melanoma	0.00102	0.00129	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Docetaxel—melanoma	0.00102	0.00479	CcSEcCtD
Gonadorelin—Asthenia—Docetaxel—melanoma	0.000989	0.00467	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CG—melanoma	0.000983	0.00125	CbGpPWpGaD
Gonadorelin—Pruritus—Docetaxel—melanoma	0.000975	0.0046	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—SYK—melanoma	0.000959	0.00122	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CD—melanoma	0.000952	0.00121	CbGpPWpGaD
Gonadorelin—Diarrhoea—Docetaxel—melanoma	0.000943	0.00445	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—AKT3—melanoma	0.000942	0.00119	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NGFR—melanoma	0.000942	0.00119	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ITGAV—melanoma	0.000942	0.00119	CbGpPWpGaD
Gonadorelin—Vomiting—Docetaxel—melanoma	0.000876	0.00414	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—SOCS1—melanoma	0.000872	0.00111	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAP2K1—melanoma	0.00087	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—S100B—melanoma	0.00087	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CD—melanoma	0.000864	0.0011	CbGpPWpGaD
Gonadorelin—Headache—Docetaxel—melanoma	0.000863	0.00407	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ERBB4—melanoma	0.000832	0.00106	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CB—melanoma	0.000829	0.00105	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CDKN2B—melanoma	0.000825	0.00105	CbGpPWpGaD
Gonadorelin—Nausea—Docetaxel—melanoma	0.000818	0.00386	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CD86—melanoma	0.000797	0.00101	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL8—melanoma	0.000797	0.00101	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDN1—melanoma	0.000791	0.001	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF1—melanoma	0.000773	0.000981	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CSF2—melanoma	0.000773	0.000981	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—IL2—melanoma	0.000762	0.000967	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—E2F1—melanoma	0.000757	0.00096	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CB—melanoma	0.000753	0.000956	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDGFRA—melanoma	0.000749	0.00095	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ITGB3—melanoma	0.000741	0.000941	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCA—melanoma	0.000741	0.000941	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SPP1—melanoma	0.000727	0.000923	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAP2K2—melanoma	0.000725	0.00092	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL8—melanoma	0.000724	0.000918	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL2—melanoma	0.000692	0.000878	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TERT—melanoma	0.000689	0.000875	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RAC1—melanoma	0.000687	0.000872	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HIF1A—melanoma	0.000659	0.000836	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KDR—melanoma	0.00063	0.0008	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FN1—melanoma	0.000607	0.00077	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NOTCH1—melanoma	0.000594	0.000753	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CD80—melanoma	0.000582	0.000738	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KIT—melanoma	0.000581	0.000737	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APC—melanoma	0.000581	0.000737	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CG—melanoma	0.000581	0.000737	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NRAS—melanoma	0.000581	0.000737	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EGF—melanoma	0.000574	0.000728	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAPK3—melanoma	0.000556	0.000706	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BRAF—melanoma	0.000546	0.000693	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF1—melanoma	0.000532	0.000675	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAPK1—melanoma	0.000529	0.000671	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—EGFR—melanoma	0.000529	0.000671	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAP2K1—melanoma	0.000514	0.000652	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CD—melanoma	0.000511	0.000648	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CA—melanoma	0.000506	0.000642	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—KRAS—melanoma	0.0005	0.000634	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF2—melanoma	0.000489	0.00062	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CA—melanoma	0.000459	0.000583	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MDM2—melanoma	0.000457	0.00058	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ERBB2—melanoma	0.000451	0.000572	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CB—melanoma	0.000445	0.000565	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL8—melanoma	0.000428	0.000543	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HRAS—melanoma	0.000425	0.000539	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CDKN1B—melanoma	0.000418	0.00053	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT1—melanoma	0.000413	0.000524	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CASP3—melanoma	0.000409	0.000519	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL2—melanoma	0.000409	0.000519	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—melanoma	0.000407	0.000516	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCND1—melanoma	0.000398	0.000505	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CTNNB1—melanoma	0.000395	0.000501	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MMP9—melanoma	0.000387	0.000491	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CDKN1A—melanoma	0.000385	0.000489	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTEN—melanoma	0.000385	0.000488	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NFKB1—melanoma	0.000383	0.000486	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT1—melanoma	0.000375	0.000476	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VEGFA—melanoma	0.000347	0.000441	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT3—melanoma	0.000344	0.000436	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NRAS—melanoma	0.000343	0.000435	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK3—melanoma	0.000329	0.000417	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MYC—melanoma	0.00032	0.000405	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK1—melanoma	0.000313	0.000397	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EGFR—melanoma	0.000313	0.000397	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KRAS—melanoma	0.000295	0.000375	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CA—melanoma	0.000271	0.000344	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TP53—melanoma	0.000262	0.000333	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HRAS—melanoma	0.000251	0.000318	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—melanoma	0.00024	0.000305	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT1—melanoma	0.000222	0.000281	CbGpPWpGaD
